Your browser doesn't support javascript.
loading
HER family in cancer progression: From discovery to 2020 and beyond.
Kumar, Rakesh; George, Bijesh; Campbell, Marcia R; Verma, Nandini; Paul, Aswathy Mary; Melo-Alvim, Cecília; Ribeiro, Leonor; Pillai, M Radhakrishna; da Costa, Luis Marques; Moasser, Mark M.
Afiliação
  • Kumar R; Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Trivandrum, Kerala, India; Department of Medicine, Division of Hematology & Oncology, Rutgers New Jersey Medical School, Newark, NJ, United States; Department of Human and Molecular Genetics, Virginia Commonwealth University, School
  • George B; Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Trivandrum, Kerala, India.
  • Campbell MR; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, United States.
  • Verma N; Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, India.
  • Paul AM; Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Trivandrum, Kerala, India.
  • Melo-Alvim C; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
  • Ribeiro L; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
  • Pillai MR; Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Trivandrum, Kerala, India.
  • da Costa LM; Medical Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Moasser MM; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, United States. Electronic address: mark.moasser@ucsf.edu.
Adv Cancer Res ; 147: 109-160, 2020.
Article em En | MEDLINE | ID: mdl-32593399

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Limite: Animals / Humans Idioma: En Revista: Adv Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Limite: Animals / Humans Idioma: En Revista: Adv Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos